Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 replication cycle.

Monique R Ferguson1, Daniel R Rojo, Jana J von Lindern

  • 1Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0435, USA. mrfergus@utmb.edu

Clinics in Laboratory Medicine
|September 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.

Frontiers in cellular and infection microbiology·2025
Same author

Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study.

World journal of diabetes·2024
Same author

Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain.

Virology·2014
Same author

Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.

PloS one·2014
Same author

Gp120 in the pathogenesis of human immunodeficiency virus-associated pain.

Annals of neurology·2014
Same author

The dual role of tetraspanin CD63 in HIV-1 replication.

Virology journal·2014

Human Immunodeficiency Virus type 1 (HIV-1) establishes persistent infections by integrating its genome and rapidly evolving. Understanding HIV-1 replication is key to developing new therapies against drug resistance.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) establishes persistent infections through proviral genome integration and rapid evolution.
  • HIV-1 utilizes novel genes and cellular machinery for replication, persistence, and regulation.
  • Current antiretroviral therapy (ART) effectiveness is challenged by HIV-1 drug resistance and treatment complexities.

Purpose of the Study:

  • To investigate the mechanisms of HIV-1 replication.
  • To identify novel therapeutic targets for combating HIV-1 drug resistance.
  • To explore strategies for continued viral suppression in patients with failing ART regimens.

Main Methods:

  • Analysis of HIV-1 replication cycle, including genome integration, gene expression, and virion assembly.

Related Experiment Videos

  • Examination of viral evolution, mutation rates, and recombination during replication.
  • Review of current antiretroviral therapies and their limitations.

    • Main Results:

    • HIV-1's ability to integrate its genome and rapid evolution contribute to persistent infection.
    • The virus hijacks host cellular machinery for efficient replication and propagation.
    • Drug resistance and treatment complexities limit the long-term success of current therapies.

    Conclusions:

    • Further research into HIV-1 replication is crucial for identifying new therapeutic targets.
    • Targeting HIV-1 entry and integration presents promising strategies for overcoming drug resistance.
    • Novel antiretroviral therapies are needed to ensure sustained viral suppression in patients.